Xermelo
NDC 70720-125, telotristat ethyl, tablet, from TerSera Therapeutics LLC.
- Product NDC
- 70720-125
- Status
- Listed
- Labeler
- TerSera Therapeutics LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208794
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70720-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TELOTRISTAT ETHYL250 mg/1
Pharmacologic classes
Tryptophan Hydroxylase Inhibitor [EPC]; Tryptophan Hydroxylase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70720-125-85 | 70720012585 | 4 BOX in 1 CASE (70720-125-85) / 1 BLISTER PACK in 1 BOX (70720-125-22) / 21 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a4ac9d62-887c-4c8f-b04d-a5f31cec7c86
Use it
Look up 70720-125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70720-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70720-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.